Imipenem and Cilastatin Sodium

DRUG2 trials

Sponsors

Jiangsu HengRui Medicine Co., Ltd.

Conditions

Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)

Phase 2

A Trial of Intravenous HRS-8427 in the Treatment of Adults With Complicate Urinary Tract Infection, Including Acute Pyelonephritis

Jiangsu HengRui Medicine Co., Ltd.Patients With Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)

Start: 2023-12-31End: 2024-07-31Target: 126Updated: 2023-11-22

Phase 3

A Trial of HRS-8427 in the Treatment of Adults With Complicated Urinary Tract Infection, Including Acute Pyelonephritis

RecruitingNCT06569056

Jiangsu HengRui Medicine Co., Ltd.Complicated Urinary Tract Infection(cUTI), Including Acute Pyelonephritis(AP)

Start: 2024-09-25End: 2025-11-30Target: 578Updated: 2025-01-22

Related Papers

Pharmacokinetics, safety, and tolerability of HRS-8427, a novel anti-carbapenem-resistant cephalosporin, in healthy subjects.

2026-03-03